Funding for this research was provided by:
National Institutes of Health (5P30CA142543, 5R01GM126479, 5R01HG008983)
Cancer Prevention and Research Institute of Texas (RP190107, RR170079)
National Cancer Institute (1R01CA245318-01, 1R01CA258524-01)
Article History
Received: 8 September 2021
Accepted: 15 August 2022
First Online: 24 August 2022
Declarations
:
: The need for Institutional Review Board Approval at our institution (University of Texas Southwestern Medical Center) was waived for this study as all data used for this project had previously been generated as part of either The Cancer Genome Atlas Project or UK Biobank and none of the results reported in this manuscript can be used to identify individual patients.
: Not applicable
: The authors declare that they have no competing interests.